2023
DOI: 10.1128/spectrum.03673-22
|View full text |Cite
|
Sign up to set email alerts
|

Oral Vaccination with Engineered Probiotic Limosilactobacillus reuteri Has Protective Effects against Localized and Systemic Staphylococcus aureus Infection

Abstract: We systematically screened and evaluated protective effects of engineered Lactobacillus against S. aureus infection in terms of differing delivery vehicle strains and S. aureus antigens and in localized and systemic infection models. Engineered L. reuteri was developed and showed strong protective effects against both types of S. aureus -induced infection.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 67 publications
(79 reference statements)
0
2
0
Order By: Relevance
“…In a novel approach, Pan et al utilized Lactobacillus reuteri WXD171-IsdB, engineered as a delivery vessel displaying S. aureus antigen IsdB, which can tolerate the gastrointestinal environment to function as an oral vaccine with less potential risk than attenuated bacterial vectors such as diphtheria toxin. They found that L. reuteri WXD171-IsdB had a strong protective effect against S. aureus pulmonary infection, skin and soft tissue infection, systemic infection, and elicited enhanced humoral and importantly, cell-mediated immunity in murine models [ 40 ]. This novel method may serve to improve the immune response in humans and requires future research as a vaccine delivery system.…”
Section: Discussionmentioning
confidence: 99%
“…In a novel approach, Pan et al utilized Lactobacillus reuteri WXD171-IsdB, engineered as a delivery vessel displaying S. aureus antigen IsdB, which can tolerate the gastrointestinal environment to function as an oral vaccine with less potential risk than attenuated bacterial vectors such as diphtheria toxin. They found that L. reuteri WXD171-IsdB had a strong protective effect against S. aureus pulmonary infection, skin and soft tissue infection, systemic infection, and elicited enhanced humoral and importantly, cell-mediated immunity in murine models [ 40 ]. This novel method may serve to improve the immune response in humans and requires future research as a vaccine delivery system.…”
Section: Discussionmentioning
confidence: 99%
“…One study found that in vitro co-colonization of human PBMCs with S. aureus and Lactobacillus strains dampened IFNγ secretion in γδ T cells, MAIT cells, and NK cells stimulated by S. aureus cell free supernatants [68]. However, recent other studies utilize Lactobacillus recombinant strains as vaccine models against S. aureus due to the commensal bacteria's ability to induce a robust immune response [69,70]. Thus, it is evident that during S. aureus infection, lactobacilli have differential effects in vitro versus in vivo and must be studied contextually.…”
Section: Cutaneous Infectionmentioning
confidence: 99%
“…Examples involve a recombinant, protein A-and IsdB-N2-containing five-antigen S. aureus vaccine (rFSAV) as well as SA4Ag, a multicomponent vaccine composed of capsular polysaccharide conjugates and recombinant forms of ClfA and the staphylococcal manganese transporter C (MntC; Creech et al, 2017 ; Frenck et al, 2017 ; Zeng et al, 2020 ). However, various clinical trials ended in failure due to adverse effects or limited efficacy in diseased patients ( Clegg et al, 2021 ), thereby asking for improved vaccination strategies that may encompass probiotic-based immunization ( Pan et al, 2023 ), advanced antibody engineering ( Chen et al, 2020 , 2022 ), or usage of live-attenuated vaccine platforms ( Cabral et al, 2017 ; Moscoso et al, 2018 ). Alternatively, chemical interference with the transpeptidase activity of sortase A may also help to limit S. aureus colonization and severity of staphylococcal disease.…”
Section: Targeting Cell Surface Proteins and Sortase A To Improve ...mentioning
confidence: 99%